SCHEMBL4011064

SCHEMBL4011064

O=C(O)n1nc(Cl)c2ccccc21

nearest known ligand 0.45

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
ELANE P08246 14/20 0.45
RORC P51449 2/20 0.43
RARG P13631 1/20 0.43
F2 P00734 2/20 0.42
PLAU P00749 2/20 0.42
KDM4E B2RXH2 1/20 0.39
HSD17B10 Q99714 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27971365 0.84 ELANE (0.54) ELANERORCRARGF2PLAU
SCHEMBL11749311 0.78 ELANE (0.49) ELANERORCF2PLAUKDM4E
SCHEMBL9952327 0.78 ELANE (0.45) ELANERORCF2PLAUKDM4E
SCHEMBL1514915 0.78 ELANE (0.60) ELANERORCF2PLAUKDM4E
SCHEMBL27578607 0.78 ELANE (0.45) ELANERORCRARGF2PLAU
SCHEMBL27758519 0.78 ELANE (0.57) ELANERORCF2PLAU
SCHEMBL11897866 0.77 ESR1 (0.38) HSD17B10MEN1KMT2A
SCHEMBL7016168 0.76 L3MBTL1 (0.44) ELANEF2PLAUMEN1KMT2A
SCHEMBL5331216 0.75 ELANE (0.43) ELANERORCRARGF2PLAU
SCHEMBL23782714 0.74 ELANE (0.49) ELANEF2PLAUKDM4EKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106170486-B Novel indazolecarboxamides, method for the production thereof, pharmaceutical preparations containing the same and use thereof for producing medicaments 拜耳医药股份有限公司 2019-01-15 CN disclosed
CN-101553492-A RAF inhibitor compounds and methods of use thereof ARRAY BIOPHARMA INC (US) 2009-10-07 CN disclosed
WO-2009009411-A1 SUBSTITUTED HETEROCYCLIC ETHERS AND THEIR USE IN CNS DISORDERS BRISTOL-MYERS SQUIBB COMPANY (US) 2009-01-15 WO disclosed